Literature DB >> 16091249

Primary human immunodeficiency virus type 1 infection.

Malini Soogoor1, Eric S Daar.   

Abstract

Primary human immunodeficiency virus type 1 (HIV-1) infection represents the initial stage of disease that immediately follows viral entry into the body. Primary infection is frequently accompanied by an acute retroviral syndrome with associated high levels of plasma HIV-1 RNA and the development of host immune responses. The identification of subjects during this period requires a high index of suspicion and an understanding of how to make the diagnosis, as standard HIV-1 antibody tests can initially be negative. Identifying these people provides a unique opportunity for early counseling to reduce further transmission, facilitates entry into care, and allows for further study of the immunopathogenesis of disease and the potential role of early antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091249     DOI: 10.1007/s11904-005-0019-1

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  48 in total

1.  Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.

Authors:  L Musey; J Hughes; T Schacker; T Shea; L Corey; M J McElrath
Journal:  N Engl J Med       Date:  1997-10-30       Impact factor: 91.245

2.  Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.

Authors:  D N Forthal; G Landucci; E S Daar
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Authors:  Frederick M Hecht; Michael P Busch; Bhupat Rawal; Marcy Webb; Eric Rosenberg; Melinda Swanson; Margaret Chesney; Jennifer Anderson; Jay Levy; James O Kahn
Journal:  AIDS       Date:  2002-05-24       Impact factor: 4.177

4.  Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?

Authors:  P Vanhems; R Allard; D A Cooper; L Perrin; J Vizzard; B Hirschel; S Kinloch-de Löes; A Carr; J Lambert
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

5.  A controlled trial of zidovudine in primary human immunodeficiency virus infection.

Authors:  S Kinloch-De Loës; B J Hirschel; B Hoen; D A Cooper; B Tindall; A Carr; J H Saurat; N Clumeck; A Lazzarin; L Mathiesen
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection.

Authors:  Bluma Brenner; Jean-Pierre Routy; Yudong Quan; Daniela Moisi; Maureen Oliveira; Dan Turner; Mark A Wainberg
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

9.  Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy.

Authors:  Niel T Constantine; Anne M Sill; Noreen Jack; Kristen Kreisel; Jeffrey Edwards; Thomas Cafarella; Harry Smith; Courtenay Bartholomew; Farley R Cleghorn; William A Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2003-01-01       Impact factor: 3.731

10.  Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohort.

Authors:  V Schiffer; C Deveau; L Meyer; I Iraqui; A Nguyen-Wartel; M-L Chaix; J-F Delfraissy; C Rouzioux; A Venet; C Goujard
Journal:  HIV Med       Date:  2004-09       Impact factor: 3.180

View more
  3 in total

1.  Association of recent HIV infection and in-utero HIV-1 transmission.

Authors:  Taha E Taha; Maria M James; Donald R Hoover; Jin Sun; Oliver Laeyendecker; Caroline E Mullis; Johnstone J Kumwenda; Jairam R Lingappa; Bertran Auvert; Charles S Morrison; Lynne M Mofensen; Allan Taylor; Mary G Fowler; Newton I Kumenda; Susan H Eshleman
Journal:  AIDS       Date:  2011-07-17       Impact factor: 4.177

2.  The prevalence and determinants of HIV seroconversion among booked ante natal clients in the University of Uyo teaching hospital, Uyo Akwa Ibom State, Nigeria.

Authors:  Nsikak Paul Nyoyoko; Augustine Vincent Umoh
Journal:  Pan Afr Med J       Date:  2016-12-21

3.  Viral Loads Within 6 Weeks After Diagnosis of HIV Infection in Early and Later Stages: Observational Study Using National Surveillance Data.

Authors:  Richard M Selik; Laurie Linley
Journal:  JMIR Public Health Surveill       Date:  2018-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.